Some relief from the epidemic. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.

Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Some relief from the epidemic. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.

GMHC Treat Issues. 1997 Mar;11(3):1-3. Unique Identifier : AIDSLINE AIDS/97702562
Cadman JA

Abstract: Death and hospitalization rates for people with AIDS dropped sharply in 1996, due to prevention of opportunistic infections, better medical care, and combination antiretroviral therapy. The Centers for Disease Control and Prevention (CDC) announced that this was the first decline since the epidemic was identified. Research specific to New York City confirms the trend. Across the country and overseas, hospital admissions for HIV and AIDS dropped. However, there is concern about disparities in the mortality rates between blacks and whites. Efforts to control the epidemic are beginning to pay off. However, AIDS is threatening to become a disease in which a patient's outcome is determined more by his social and financial status than by the state of medicine.

Keywords: AIDS-Related Opportunistic Infections/*PREVENTION & CONTROL Acquired Immunodeficiency Syndrome/DRUG THERAPY/EPIDEMIOLOGY/ *MORTALITY Anti-HIV Agents/THERAPEUTIC USE Centers for Disease Control and Prevention (U.S.) Drug Costs Drug Therapy, Combination Female HIV Infections/DRUG THERAPY HIV Protease Inhibitors/THERAPEUTIC USE Health Services Accessibility Hospitalization/STATISTICS & NUMER DATA Human Lamivudine/THERAPEUTIC USE Male New York City/EPIDEMIOLOGY Population Surveillance Prevalence United States/EPIDEMIOLOGY NEWSLETTER ARTICLE
970830
M9781189

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .